Oral contraception and eye disease: findings in two large cohort studies

被引:32
作者
Vessey, MP [1 ]
Hannaford, P
Mant, J
Painter, R
Frith, P
Chappel, D
机构
[1] Univ Newcastle Upon Tyne, Sch Med, Div Epidemiol & Publ Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Inst Hlth Sci, Dept Publ Hlth, Oxford OX3 7LF, England
[3] Foresterhill Hlth Ctr, Dept Gen Practice & Primary Care, Aberdeen AB25 2AY, Scotland
[4] Radcliffe Infirm, Oxford Eye Hosp, Oxford OX2 6HE, England
[5] Univ Newcastle Upon Tyne, Sch Med, Div Epidemiol & Publ Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
关键词
D O I
10.1136/bjo.82.5.538
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aim-To investigate the relation between oral contraceptive use and certain eye diseases. Methods-Abstraction of the relevant data from the two large British cohort studies of the effects of oral contraception, the Royal College of General Practitioners' (RCGP) Oral Contraception Study and the Oxford-Family Planning Association (Oxford-FPA) Contraceptive Study. Bath cohort studies commenced in 1968 and were organised on a national basis. Between them they have accumulated over 850000 person years of observation involving 63000 women. Results-The conditions considered in the analysis were conjunctivitis, keratitis, iritis, lacrimal disease, strabismus, cataract, glaucoma, retinal detachment, and retinal vascular lesions. With the exception of retinal vascular lesions, there was no consistent evidence of important increases in risk of eye diseases in users of oral contraception. There was about a twofold increase in the risk of retinal vascular lesions in recent pill users in both studies (statistically significant only in the RCGP study). The increase was not Limited to any specific type of lesion and may well reflect diagnostic bias. Conclusion-Oral contraceptive use does not appear to increase the risk of eye disease, with the possible exception of retinal vascular lesions.
引用
收藏
页码:538 / 542
页数:5
相关论文
共 12 条
  • [1] Beral V, 1996, EVIDENCE GUIDED PRES, P327
  • [2] Breslow NE, 1987, STAT METHODS CANC RE, VII
  • [3] Cumming RG, 1997, AM J EPIDEMIOL, V145, P242
  • [4] ORAL-CONTRACEPTIVES AND RENAL AND RETINAL COMPLICATIONS IN YOUNG-WOMEN WITH INSULIN-DEPENDENT DIABETES-MELLITUS
    GARG, SK
    CHASE, HP
    MARSHALL, G
    HOOPS, SL
    HOLMES, DL
    JACKSON, WE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (14): : 1099 - 1102
  • [5] Combined oral contraceptives and liver disease
    Hannaford, PC
    Kay, CR
    Vessey, MP
    Painter, R
    Mant, J
    [J]. CONTRACEPTION, 1997, 55 (03) : 145 - 151
  • [6] IS THERE EVIDENCE OF AN ESTROGEN EFFECT AGE-RELATED LENS OPACITIES - THE BEAVER DAM EYE STUDY
    KLEIN, BEK
    KLEIN, R
    RITTER, LL
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1994, 112 (01) : 85 - 91
  • [7] RADNOT M, 1973, ANN CLIN RES, V5, P197
  • [8] *ROYAL COLL GEN PR, 1974, OR CONTR HLTH
  • [9] Thorogood M., 1993, PHARMACOEPIDEMIOL DR, V2, P3
  • [10] VARGA M, 1976, Annals of Ophthalmology, V8, P925